China Merchants Fund Leads $25M Round In Gene-Editing Start-Up Qihan Biotech
September 23, 2019 — 13:31 CST
This Data Is Locked!
This area is available only to Subscribers.
Qihan Biotech, a Hangzhou-based biotech startup focused on organ transplantation, announced on Monday that it has raised US$25.5 million in a series A+ funding round.... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals